found that, Single-cell sequencing in high-grade serous ovarian cancer (HGSOC) has shown that ERBB2 is highly expressed in metastatic tumors, and IL6/STAT3 signaling is enriched in fibroblasts and involved in angiogenesis and immune regulation (16). This evidence concerns the gene ERBB2 and ovarian serous adenocarcinoma.